Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
39 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Vanderbilt University (Vanderbilt) is a medical and research university that provides professional degrees. The university offers graduate and undergraduate degrees in the fields of engineering, music, liberal arts and sciences, education and human development. It provides services such as clinical research and research support services. Vanderbilts research support services includes study organization, IRB navigation, training, protocol development, preparation of study related documents, funding and contractual agreements and overall program advisory.

Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal

  
Source:
Document ID
GDPH63465D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Vanderbilt University, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Vanderbilt University, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Vanderbilt University, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Vanderbilt University, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Vanderbilt University, Medical Devices Deals, 2010 to YTD 201691
Vanderbilt University, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
Vanderbilt University, Pharmaceuticals &Healthcare, Deal Details1223
  Partnerships121
    Illumina Enters into Agreement with Vanderbilt University121
    Diatherix Labs Enters into Research Agreement with Vanderbilt University Medical Center131
    MedImmune, GlaxoSmithKline and Vanderbilt University Enter into Agreement141
    BioReference Labs Enters into Co-Development Agreement with Vanderbilt-Ingram151
    Incyte Enters into Research Agreement with Vanderbilt University Medical Center161
    Vanderbilt University Enters Into Research Agreement With GlaxoSmithKline For Obesity Drug172
    Baptist Memorial Health Care Enters Into Research Agreement With Vanderbilt University191
    Vanderbilt University Enters Into Agreement With Bristol-Myers Squibb To Develop Drugs For Parkinson s Disease202
    Scripps Research Enters Into Joint Venture Agreement With Vanderbilt University222
    Seaside Therapeutics Enters Into Research Collaboration With Vanderbilt University241
  Licensing Agreements251
    La Jolla Pharma Enters into Licensing Agreement with Vanderbilt University251
    AstraZeneca Enters into Licensing Agreement with Vanderbilt University261
    AstraZeneca Enters Into Licensing Agreement With Vanderbilt University For Neuroscience Drug Discovery271
    Parker Hannifin Enters Into Licensing Agreement With Vanderbilt University For Exoskeleton Technology282
    Nanoferix Enters into Licensing Agreement with Vanderbilt University Center for Technology Transfer and Commercialization301
    Vanderbilt University Enters Into Licensing Agreement With Karuna Pharma311
  Asset Transactions321
    Cumberland Pharma Acquires Rights Of Ifetroban From Vanderbilt University322
  Acquisition341
    Vanderbilt University Sells Microarrays341
Vanderbilt University - Key Competitors351
Key Employees361
Locations And Subsidiaries372
  Head Office371
  Other Locations &Subsidiaries372
Appendix391
  Methodology391
  About GlobalData391
  Contact Us391
  Disclaimer391

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Vanderbilt-University-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17175>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Vanderbilt-University-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17175>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research